|
SPEN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.400400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.675100E-03 |
| Normal-vs-Stage2 |
1.968110E-02 |
| Normal-vs-Stage3 |
9.201200E-04 |
| Normal-vs-Stage4 |
2.558500E-04 |
| Stage1-vs-Stage2 |
5.635800E-01 |
| Stage1-vs-Stage3 |
1.748250E-01 |
| Stage1-vs-Stage4 |
5.711900E-02 |
| Stage2-vs-Stage3 |
6.986800E-01 |
| Stage2-vs-Stage4 |
3.382800E-01 |
| Stage3-vs-Stage4 |
4.708400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.161300E-03 |
| Normal-vs-AfricanAmerican |
1.675190E-03 |
| Normal-vs-Asian |
3.777900E-04 |
| Caucasian-vs-AfricanAmerican |
4.359400E-01 |
| Caucasian-vs-Asian |
1.677920E-02 |
| AfricanAmerican-vs-Asian |
1.628050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.080360E-03 |
| Normal-vs-Female |
5.838000E-01 |
| Male-vs-Female |
1.176000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.219400E-03 |
| Normal-vs-Extreme_Weight |
1.016010E-02 |
| Normal-vs-Obese |
1.818190E-01 |
| Normal-vs-Extreme_Obese |
8.212500E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.523600E-01 |
| Normal_Weight-vs-Obese |
8.243600E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.811600E-01 |
| Extreme_Weight-vs-Obese |
2.541400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.206200E-01 |
| Obese-vs-Extreme_Obese |
1.124410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.188000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.583800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.11389999999323E-05 |
| Normal-vs-Age(81-100Yrs) |
2.959600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.646400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.068000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.507820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.756100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.327000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.100200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.482300E-02 |
| Normal-VS-Type2 PRCC |
4.3948999994825E-08 |
| Normal-VS-KIRP CIMP |
2.838400E-02 |
| Normal-VS-Unclassified PRCC |
6.204600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.50984999999215E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.484400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.591400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.349600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.977900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.535800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.52580000004166E-06 |
| Normal-vs-N1 |
6.095100E-03 |
| Normal-vs-N2 |
6.169800E-02 |
| N0-vs-N1 |
3.127800E-01 |
| N0-vs-N2 |
7.103200E-01 |
| N1-vs-N2 |
9.026400E-01 |
|
|
